PUBLISHER: Grand View Research | PRODUCT CODE: 1842105
PUBLISHER: Grand View Research | PRODUCT CODE: 1842105
The global cardiac rhythm management devices market size was estimated at USD 14.41 billion in 2024 and is projected to reach USD 18.77 billion by 2033, growing at a CAGR of 2.92% from 2025 to 2033. Various technological advancements related to the market, such as the integration of AI, remote monitoring, and wearable technology, are anticipated to fuel the market growth.
The growing prevalence of various cardiovascular diseases, such as arrhythmia and atrial fibrillation, among others. According to the Centers for Disease Control and Prevention (CDC), around 12.1 million people in the U.S. are expected to suffer from atrial fibrillation (AFib) by 2030.
The widespread impact of cardiovascular disease (CVD) is a key aspect boosting the growth and innovation within the cardiac monitoring and cardiac rhythm management devices market. According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches about 7,179 cases per 100,000 people, underscoring the significant and ongoing impact of heart conditions globally. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. This fuels demand for cardiac monitoring and cardiac rhythm management devices, critical for identifying abnormal heart rhythms, managing chronic heart conditions, and reducing the risk of serious cardiac events
Global Cardiac Rhythm Management Devices Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cardiac rhythm management devices market report based on product, end-use, and region: